Once diagnosed, feline hyperthyroidism requires lifelong management. Understanding the treatment options and their welfare implications enables owners and vets to maximise quality of life for affected cats.
The welfare of long-term managed hyperthyroid cats depends on selecting a treatment modality matched to the individual cat's health status, owner capacity, and concurrent disease profile. Radioactive iodine is the gold standard on welfare grounds — a curative treatment eliminates the daily stress of medication administration and achieves permanent normalisation of thyroid function. For cats in which radioiodine is not accessible or where concurrent disease complicates it, oral methimazole provides effective control but the welfare cost of twice-daily pilling must be acknowledged and managed through pill-hiding techniques, formulation alternatives, or compounded palatable preparations. The discovery of concurrent kidney disease after starting hyperthyroid treatment represents a complex welfare challenge requiring individualised management planning.